Lynn Schenk, Director at BIOGEN IDEC INC. (BIIB), sold 14,455 shares at $135.00 ($2.0M) on 2012-05-02, disclosed to the SEC on 2012-05-03.
Scheduled sale ($2.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.00 | 5,975 | $807K | 41.3% |
| 2 | $135.00 | 8,480 | $1.1M | 58.7% |
| Total | $135.00 avg | 14,455 | $2.0M | 100% |
| Filing → |
| SRE | SELL | 2014-06-19 | $263K | — | Filing → |
| BIIB | SELL | 2014-01-16 | $297K | — | Filing → |
| BIIB | SELL | 2013-12-02 | $292K | — | Filing → |